Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC)

Neurochemical Research

Volumn 25, Issue 5, 2000, Pages 613-619

  Wang, Jing Hung ^a   Sun, Grace Y ^a  

^a University of Missouri   (United States)

Author keywords

Astrocytes; Cytokines; INOS; PAF antagonists; SPLA2; Transcription factor

Indexed keywords

6 (2 CHLOROPHENYL) 4,7,8,10 TETRAHYDRO 9 (4 METHOXYPHENYLCARBAMOYL) 1 METHYLPYRIDO[4',3'; NITRIC OXIDE SYNTHASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BRAIN INJURY; CELL IMMORTALIZATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

ANIMALS; ASTROCYTES; AZEPINES; CELL LINE, TRANSFORMED; CYTOKINES; DITERPENES; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GINKGOLIDES; INTERFERON TYPE II; INTERLEUKIN-1; LACTONES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033933960     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007550801444     Document Type: Article

References (31)

1. Bussolino, F., Soldi, R., Arese, M., Jaranowska, A., Sogos, V., and Gremo, F. 1995. Multiple roles of platelet-activating factor in the nervous system. Neurochem. Int. 26:425-433.
2. Bazan, N. G., Packard, M. G., Teather, L., and Allan, G. 1997. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. [Review]. Neurochem. Int. 30:225-231.
3. Bazan, N. G. 1998. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. [Review]. Progress Brain Res. 118:281-291.
4. Teather, L. A., Packard, M. G., and Bazan, N. G. 1998. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. Neurobiol. Learning & Memory. 70:349-363.
5. Bito, H., Kudo, Y., and Shimizu, T. 1993. Characterization of platelet-activating factor (PAF) receptor in the rat brain. J. Lipid Mediators. 6:169-174.
6. Izumi, T., and Shimizu, T. 1995. Platelet-activating factor receptor: gene expression and signal transduction. [Review] Biochem. Biophys. Acta. 1259:317-333.
7. Shimuzu, T., Mori, M., Bito, H., Sakanaka, C., Tabuchi, S., Aihara, M., and Kume, K. 1996. Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release. [Review] J. Lipid Mediators & Cell Signalling. 14:103-108.
8. Calcerrada, M. C., Catalan, R. E., Perez-Alvarez, M. J., Miguel, B. G., and Martinez, A. M. 1999. Platelet-activating factor stimulation of p125 (FAK) and p130 (Cas) tyrosine phosphorylation in brain. Brain Res. 835:275-281.
9. Marcheselli, V. L., Rossowska, M. J., Domingo, M. T., Braquet, P., and Bazan, N. G. 1990. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265:9140-9145.
10. Marcheselli, V. L., and Bazan, N. G. 1994. Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcription activation of c-fos and zif-268 in hippocampus. J. Neurosci. Res. 37:54-61.
11. DeCoster, M. A., Mukherjee, P. K., Davis, R. J., and Bazan, N. G. 1998. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. J. Neurosci. Res. 53: 297-303.
12. Mukherjee, P. K., DeCoster, M. A., Campbell, F. Z., Davis, R. J., and Bazan, N. G. 1999. Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. J. Biol. Chem. 274:6493-6498.
13. Marcheselli, V. L., and Bazan, N. G. 1996. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J. Biol. Chem. 271:24797-24799.
14. Bazan, N. G., and Rodriguez de Turco, E.B. 1995. Platelet-activating factor is a synapse messenger and a modulator of gene expression in the nervous system. Neurochem. Int. 26: 435-441.
15. Smith, P. F., Maclennan, K., and Darlington, C. L. 1996. The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-activating factor (PAF). [Review]. J. Ethnopharmacology. 50:131-139.
16. Pietri, S., Maurelli, E., Drieu, K., and Culcasi, M. 1997. Cardio-protective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (Egb 761). J. Mol. & Cellular Cardiology. 29:733-742.
17. Negro Alvarez, J. M., Miralles Lopez, J. C., Ortiz Martinez, J. L., Abellan Aleman, A., and Rubio del Barrio, R. 1997. Platelet-activating factor antagonists. [Review]. Allergologia et Immunopathologia. 25:249-258.
18. Silva, C. L. M., Cruz, H. N., Violante, F. A., Cordeiro, R. S. B., Martins, M. A., and Noel, F. 1996. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 metyl-1 (chloro-2 phenyl)-6(methoxy-4 phenyl-carbamoyl)-9 pyrido [4′,3′-4,5]thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes. Biochem. Pharmacol. 51:193-196.
19. 2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha, and IL- 1 beta. Interactive effects. Mol. Chem. Neuropathol. 25:1-17.
20. 2 in immortalized astrocytes: response to genistein and pyrrolidine dithiocarbamate (PDTC). J. Interferon and Cytokine Res. 19:121-127.
21. 2 in immortalized astrocytes (DITNC). J. Mol. Neurosci. 12:89-99.
22. 2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187. Neurochem. Res. 24:1285-1291.
23. Cardile, V., Jiang, X., Renis, M., and Bindoni, M. 1996. 1-O-octadecyl-2-methoxy-racglycero-3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes. Brain Res. 715:98-103.
24. Du, Z. Y., and Li, X. Y. 1998. Inhibitory effects of ginkgolides on nitric oxide production in neonatal rat microglia in vitro. Acta Pharmacol. Sinica. 19:467-470.
25. Mori, M., Aihara, M., Kume, K., Hamanoue, M., Kohsaka, S., and Shimizu, T. 1996. Predominant expression of platelet-acivating factor receptor in the rat brain microglia. J. Neurosci. 16:3590-3600.
26. Han, S. J., Choi, J. H., Ko, H. M., Yang, H. W., Choi, I. W., Lee, H. K., Lee, O. H., and Im, S. Y. 1999. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Europ. J. Immunol. 29:1334-1341.
27. Im, S. Y., Han, S. J., Ko, H. M., Choi, J. H., Chun, S. B., Lee, D. G., Ha, T. Y., and Lee, H. K. 1997. Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur. J. Immunol. 27:2800-2804.
28. Lo, C. J., Cryer, H. G., Fu, M., and Kim, B. 1997. Endotoxin-induced macrophage gene expression depends on platelet activating factor. Archives Surgery 132:1342-1347.
29. Hilliquin, P., Natour, J., Asissa, J., Guinot, P., Laoussadi, S., Benveniste, J., Menkes, C. J., and Arnoux, B. 1995. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730. Annals Rheumatic Diseases. 54:140-143.
30. Jancar, S., Abdo, E. E., Sampietre, S. N., Kwasniewski, F. H., Coelho, A. M., Bonizzia, A., Machado, M. C. 1995. Effect of PAF antagonists on cerulein-induced pancreatitis. J. Lipid Mediators & Cell Signalling. 11:41-49.
31. Pires AL, e Silva PM, Pasquale C, Castro-Faria-Neto HC, Bozza PT, Cordeiro RS, Rae GA, Braquet P, Lagente V, and Martins MA. 1994. Long-lasting inhibitory activity of the hetrazepine BN 50730 on exudation and cellular alterations evoked by PAF and LPS. Brit. J. Pharmacol. 113:994-1000.